Nuclear Oncology Experts
Company

Nuclear Oncology Experts

Hospitals And Health Care Gurgaon, Haryana, In 31 employees
Employees
31

Nuclear Oncology Experts Overview

Headquarters
Gurgaon, Haryana, In
Industry
Hospitals And Health Care
Employees
31
Founded
2015
NAICS
Health Care and Social Assistance
Social Assistance

About Nuclear Oncology Experts

The team of Nuclear Oncology Experts is a group of dedicated Nuclear Medicine Physicians, Dosimetrists, Radiochemists and Nuclear Medicine technologists with extensive experience in Nuclear Medicine Diagnostics and Therapies. Operating from the Department of Nuclear Medicine & Molecular Imaging, Fortis Memorial Research Institute (FMRI), Gurgaon in the state of Haryana, India, the centre is the first-of-its-kind dedicated Nuclear Oncology Diagnostic and Therapeutic setup in India. With internationally trained experts and world class facilities, the team ensures that the regimens and protocols followed at the centre are at par with the highest standards in the world. All cases are first discussed in a multi-disciplinary board that includes Medical, Radiation & Surgical Oncologists; Pathologists and Radiologists. Each member of this team is specially trained in performing highly sophisticated Targeted Radionuclide Therapy that targets the tumours with minimal damage to the surrounding tissue. The Nuclear Oncology Experts team is led by Dr. Ishita Sen, Director & Head, Department of Nuclear Medicine at FMRI. Trained at the MSKCC for thyroid cancer, she is one of the pioneers of Radionuclide Therapy especially Targeted Alpha Therapy in India. The other dynamic and qualified doctors in the team are Dr. Vineet Pant, MBBS, DNB, FEBNM Fellow Theranostics and Dr. Sugandha Dureja, MBBS, DNB, FEBNM Fellow Theranostics. Dr. Pant, a Senior Consultant & Unit Head at the centre is a Fellow Theranostics from ENETS Centre of Excellence, Bad Berka Hospital, Germany. Experienced in Radionuclide Therapy in Hyperthyroidism, his area of expertise is treatment of Thyroid Cancer with Radioiodine Therapy; treatment of Neuroendocrine Tumour with Lu-177 PRRT; and treatment of Metastatic Castration Resistant Prostate Cancer with Lu-177 PSMA Therapy. Dr. Dureja is among the first Indian doctors to be trained at the Theranostics Centre for Molecular Therapy, Bad Berka, Germany.

Compare Similar Companies to Nuclear Oncology Experts